Bit Capital Gmb H Fate Therapeutics Inc Transaction History
Bit Capital Gmb H
- $1.26 Trillion
- Q4 2024
A detailed history of Bit Capital Gmb H transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Bit Capital Gmb H holds 247,564 shares of FATE stock, worth $299,552. This represents 0.03% of its overall portfolio holdings.
Number of Shares
247,564Holding current value
$299,552% of portfolio
0.03%Shares
3 transactions
Others Institutions Holding FATE
# of Institutions
168Shares Held
113MCall Options Held
53.7KPut Options Held
9K-
Redmile Group, LLC San Francisco, CA13.2MShares$15.9 Million3.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$12.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$12.2 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.57MShares$6.74 Million0.72% of portfolio
-
State Street Corp Boston, MA5.25MShares$6.36 Million0.0% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $117M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...